C07F 9/44
Amides thereof
C07F9/44 (Amides thereof) appears on 258 US grants and 137 published applications in this corpus.
Search patents in C07F- Granted patents
- 258
- Published applications
- 137
- Assignees
- 111
- Inventors
- 458
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 25 | 0 |
| 1977 | 5 | 0 |
| 1978 | 3 | 0 |
| 1979 | 6 | 0 |
| 1980 | 7 | 0 |
| 1981 | 5 | 0 |
| 1982 | 3 | 0 |
| 1983 | 8 | 0 |
| 1984 | 5 | 0 |
| 1985 | 7 | 0 |
| 1986 | 1 | 0 |
| 1987 | 7 | 0 |
| 1988 | 0 | 0 |
| 1989 | 4 | 0 |
| 1990 | 5 | 0 |
| 1991 | 5 | 0 |
| 1992 | 5 | 0 |
| 1993 | 12 | 0 |
| 1994 | 0 | 0 |
| 1995 | 5 | 0 |
| 1996 | 9 | 0 |
| 1997 | 2 | 0 |
| 1998 | 5 | 0 |
| 1999 | 3 | 0 |
| 2000 | 8 | 0 |
| 2001 | 4 | 1 |
| 2002 | 6 | 4 |
| 2003 | 3 | 5 |
| 2004 | 6 | 11 |
| 2005 | 6 | 7 |
| 2006 | 5 | 7 |
| 2007 | 2 | 7 |
| 2008 | 4 | 2 |
| 2009 | 3 | 4 |
| 2010 | 6 | 3 |
| 2011 | 2 | 1 |
| 2012 | 4 | 8 |
| 2013 | 5 | 10 |
| 2014 | 6 | 5 |
| 2015 | 8 | 5 |
| 2016 | 3 | 2 |
| 2017 | 3 | 5 |
| 2018 | 5 | 7 |
| 2019 | 5 | 11 |
| 2020 | 6 | 5 |
| 2021 | 5 | 6 |
| 2022 | 2 | 5 |
| 2023 | 4 | 6 |
| 2024 | 5 | 4 |
| 2025 | 2 | 1 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Phosphoantigen prodrug compounds1 Sep 2026US 12,723,055 B2The University of Birmingham
- Cannabidiol derivatives, preparation method thereof and use thereof10 Feb 2026US 12,545,694 B2Chengdu Baiyu Pharmaceutical Co., Ltd
- Inhibitors of phospholipid synthesis and methods of use3 Feb 2026US 12,540,115 B2The Board of Trustees of the Leland Stanford Junior University
- Heterocyclic THR-β receptor agonist compound and preparation method and use therefor5 Aug 2025US 12,378,268 B2Hepagene Therapeutics (HK) Limited
- Cannabinoid derivatives18 Mar 2025US 12,252,503 B2Canopy Growth Corporation
- Novel phosphoantigen prodrug compound and use thereof8 Oct 2026US 2026/0306541 A1
- Modulator for promoting binding of butyrophilin 3a1/2a130 Jul 2026US 2026/0216219 A1Unicet Biotech Co. LLC.
- Prodrugs of dimethoxyphenylalkylamine activators of serotonin receptors23 Jul 2026US 2026/0207636 A1
- Modulator for promoting binding of butyrophilin 3a1/2a123 Jul 2026US 2026/0207637 A1Unicet Biotech Co. LLC.
- Hydroxyaminophosphinic acid derivatives14 May 2026US 2026/0132157 A1Merck Patent GmbH
Most cited
By later US patents
- Inhibitors of NAALADase enzyme activity97US 5,795,877 AGuilford Pharmaceuticals Inc. · 1998
- Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof75US 6,511,990 B1Sloan-Kettering Institute for Cancer Research · 2003
- Phosphoramidate derivatives73US 5,863,536 AGuilford Pharmaceuticals Inc. · 1999
- Sulfide and disulfide compounds and compositions for cholesterol management and related uses68US 6,703,422 B2Esperion Therapeutics, Inc. · 2004
- Naaladase inhibitors67US 5,968,915 AGuilford Pharmaceuticals Inc. · 1999